eClinical Solutions has announced expanded artificial intelligence (AI) and machine learning (ML) capabilities within the elluminate IQ offering. Embedded in elluminate Data Central, the elluminate Clinical Data Cloud’s data management workbench provides access to trial data across systems and sources. elluminate IQ Review (eIQ Review) enables data management teams to utilize these AI/ML capabilities to conduct data review.
The elluminate platform including the expanded eIQ Review capabilities will be featured at industry events across the US and Europe this spring.
eClinical Solutions Expands elluminate IQ Offering for AI-Enabled Data Review to Deliver Increased Efficiencies and Quality to Clinical Data Management. (2023, May 24). Business Wire.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.